Exhibit 99.1 "As announced earlier this week, we strengthened our European operations through the acquisition of Interworks, enhancing our Microsoft relationship and expanding our presence to Greece, Albania, Italy, Bulgaria and Romania. This transaction reflects our targeted and accretive M&A strategy, which focuses on expanding our geographic footprint, strengthening our line card and adding complementary capabilities to our platform. Interworks not only broadens our reach in high-growth European markets, ...

Exhibit 99.1 The Honest Company Reports Fourth Quarter and Full Year 2025 Financial Results Achieves 2025 Full Year Financial Outlook In Line with Updated Guidance Announces $25 Million Inaugural Share Repurchase Authorization Provides Full Year 2026 Financial Outlook In Line with Long-Term Algorithm LOS ANGELES, Calif. – February 25, 2026 – The Honest Company (Nasdaq: HNST), a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [Mark One] ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 001-33057 CATALYST PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 76-0837053 (State of jurisdiction of incorporation ...

EXHIBIT 99.1 BJ's Restaurants, Inc. Reports Fiscal Fourth Quarter and Fiscal Year 2025 Results Issues 2026 Financial Outlook HUNTINGTON BEACH, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- BJ's Restaurants, Inc. (NASDAQ: BJRI) today reported financial results for its fiscal 2025 fourth quarter and year ended December 30, 2025. Fiscal Fourth Quarter 2025 Compared to Fourth Quarter 2024 Total revenues increased 3.2% to $355.4 million Comparable restaurant sales increased 2.6% Restaurant level operating profit was ...

Exhibit 99.1 G. Janelle Frost President & CEO AMERISAFE 337.463.9052 AMERISAFE ANNOUNCES 2025 FOURTH QUARTER AND YEAR-END RESULTS Reports 10.2% Growth in Voluntary Premiums on Policies Written and Return on Equity of 18.5% in 2025 DeRidder, LA – February 25, 2026 – AMERISAFE, Inc. (Nasdaq: AMSF), a specialty provider of workers' compensation insurance focused on high-hazard industries, today announced results for the fourth quarter and year ended December 31, 2025. | | Three Months Ended | | | | Twelve Mont ...

"In the fourth quarter, we delivered our highest procedure volume to date—approximately 12,200—and sold 65 new systems, marking our strongest capital quarter," said Larry Wood, Chief Executive Officer. "At the same time, we took meaningful steps to position the Company for its next phase of growth. To sharpen our focus on delivering durable procedure growth, we realigned our commercial organization, established a dedicated launch team to reduce activation variability, and implemented a more disciplined hand ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33647 _____________________________________________________________________________________________________________ ...

Exhibit 99.1 ARKO Corp. Reports Fourth Quarter and Full Year 2025 Results ARKO Corp. (Nasdaq: ARKO) ("ARKO" or the "Company"), a Fortune 500 company and one of the largest operators of convenience stores and wholesalers of fuel in the United States, today announced financial results for the fourth quarter and the full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Key Highlights (vs. Year-Ago Period) 1,2 Other Key Highlights 1 See Use of Non-GAAP Measures below. 2 All figures for fuel costs ...

Exhibit 99.1 Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress REDWOOD CITY, Calif., Feb 25, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced its financial results for the quarter and full year ended December 31, 2025, and provided an update on corporate progress. "We made substantial clinical progress ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________________________ FORM 10-K ___________________________________________________ (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39275 _____ ...